Bank of America: Net Interest Income is Only Half the Story Bank of America Corp (NYSE:BAC) delivered better-than-expected second-quarter results, posting EPS of $0.46 compared …
CymaBay Therapeutics Inc (NASDAQ:CBAY) shares jumped nearly over 20% in Monday’s trading session, after the company announced positive interim results from its ongoing low-dose …
Today was an explosive day in the biotech-verse as CymaBay Therapeutics Inc (NASDAQ:CBAY) shot up on back of H.C.
In a research report issued today, Roth Capital analyst Ed Arce maintained a Buy rating on CymaBay Therapeutics (NASDAQ:CBAY) with a $14 price target, …
